SEC Form 4 · accession 0001209191-16-122637
Dimension Therapeutics, Inc. · DMTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Arlene Morris
Director
Period of report
May 19, 2016
Accepted (ET)
May 23, 2016 · 4:39 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001592288
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $7.08 | May 19, 2016 | A | 32,069 | A | — | May 18, 2026 | Common Stock | 32,069 | 32,069 | D |
Explanation of responses
- F1The options shall vest in full on the earlier of May 19, 2017 or the Issuer's next annual meeting of stockholders, subject to the director's continued service on the Board.